T cell cytokines and the risk of blood stream infection in extremely low birth weight infants

Cytokine

Volumn 53, Issue 2, 2011, Pages 249-255

  Schelonka, Robert L ^a   Maheshwari, Akhil ^a   Carlo, Waldemar A ^a   Taylor, Sarah ^b   Hansen, Nellie I ^b   Schendel, Diana E ^c   Thorsen, Poul ^d   Skogstrand, Kristin ^e   Hougaard, David M ^e   Higgins, Rosemary D ^f  

^a University of Alabama at Birmingham   (United States)

^b RTI INTERNATIONAL   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d KOLDING HOSPITAL   (Denmark)

^e STATENS SERUM INSTITUT   (Denmark)

^f EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

Cytokine; Infection; Neonate; Sepsis

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; LYMPHOTOXIN;

ARTICLE; BACTERIAL INFECTION; BLOODSTREAM INFECTION; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTREMELY LOW BIRTH WEIGHT; FEMALE; HUMAN; IMMUNOREGULATION; INFANT; INFLAMMATION; MAJOR CLINICAL STUDY; MALE; MYCOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RISK ASSESSMENT; RISK FACTOR; T LYMPHOCYTE;

CYTOKINES; FEMALE; GESTATIONAL AGE; HUMANS; INFANT, EXTREMELY LOW BIRTH WEIGHT; INFANT, NEWBORN; INFECTION; MALE; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; T-LYMPHOCYTES; TH1 CELLS; TH17 CELLS; TH2 CELLS; TIME FACTORS;

EID: 78651065638     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.11.003     Document Type: Article

References (30)

1. Stoll B.J., Hansen N., Fanaroff A.A., Wright L.L., Carlo W.A., Ehrenkranz R.A., et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002, 110:285-291.
2. Bizzarro M.J., Raskind C., Baltimore R.S., Gallagher P.G. Seventy-five years of neonatal sepsis at Yale: 1928-2003. Pediatrics 2005, 116:595-602.
3. Christensen R.D., Rothstein G. Exhaustion of mature marrow neutrophils in neonates with sepsis. J Pediatr 1980, 96:316-318.
4. Christensen R.D., Brown M.S., Hall D.C., Lassiter H.A., Hill H.R. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. J Pediatr 1991, 118:606-614.
5. Schelonka R.L., Raaphorst F.M., Infante D., Kraig E., Teale J.M., Infante A.J. T cell receptor repertoire diversity and clonal expansion in human neonates. Pediatr Res 1998, 43:396-402.
6. Schroeder H.W., Zhang L., Philips J.B. Slow, programmed maturation of the immunoglobulin HCDR3 repertoire during the third trimester of fetal life. Blood 2001, 98:2745-2751.
7. Schelonka R.L., Infante A.J. Neonatal immunology. Semin Perinatol 1998, 22:2-14.
8. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., Coffman R.L. Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 1986, 136:2348-2357.
9. Schaub B., Liu J., Schleich I., Hoppler S., Sattler C., von M.E. Impairment of T helper and T regulatory cell responses at birth. Allergy 2008, 63:1438-1447.
10. Adkins B., Leclerc C., Marshall-Clarke S. Neonatal adaptive immunity comes of age. Nat Rev Immunol 2004, 4:553-564.
11. Mills K.H. Induction, function and regulation of IL-17-producing T cells. Eur J Immunol 2008, 38:2636-2649.
12. Weaver C.T., Hatton R.D., Mangan P.R., Harrington L.E. IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu Rev Immunol 2007, 25:821-852.
13. Skogstrand K., Thorsen P., Norgaard-Pedersen B., Schendel D.E., Sorensen L.C., Hougaard D.M. Simultaneous measurement of 25 inflammatory markers and neurotrophins in neonatal dried blood spots by immunoassay with xMAP technology. Clin Chem 2005, 51:1854-1866.
14. Skogstrand K., Ekelund C.K., Thorsen P., Vogel I., Jacobsson B., Norgaard-Pedersen B., et al. Effects of blood sample handling procedures on measurable inflammatory markers in plasma, serum and dried blood spot samples. J Immunol Methods 2008, 20(336):78-84.
15. Shurin M.R., Lu L., Kalinski P., Stewart-Akers A.M., Lotze M.T. Th1/Th2 balance in cancer, transplantation and pregnancy. Springer Semin Immunopathol 1999, 21:339-359.
16. Krueger M., Nauck M.S., Sang S., Hentschel R., Wieland H., Berner R. Cord blood levels of interleukin-6 and interleukin-8 for the immediate diagnosis of early-onset infection in premature infants. Biol Neonate 2001, 80:118-123.
17. Nupponen I., Andersson S., Jarvenpaa A.L., Kautiainen H., Repo H. Neutrophil CD11b expression and circulating interleukin-8 as diagnostic markers for early-onset neonatal sepsis. Pediatrics 2001, 108:E12.
18. Martin H., Olander B., Norman M. Reactive hyperemia and interleukin 6, interleukin 8, and tumor necrosis factor-alpha in the diagnosis of early-onset neonatal sepsis. Pediatrics 2001, 108:E61.
19. Dollner H., Vatten L., Austgulen R. Early diagnostic markers for neonatal sepsis: comparing C-reactive protein, interleukin-6, soluble tumour necrosis factor receptors and soluble adhesion molecules. J Clin Epidemiol 2001, 54:1251-1257.
20. Waites K.B., Schelonka R.L., Xiao L., Grigsby P.L., Novy M.J. Congenital and opportunistic infections: Ureaplasma species and Mycoplasma hominis. Semin Fetal Neonatal Med 2008.
21. Gotsch F., Romero R., Kusanovic J.P., Mazaki-Tovi S., Pineles B.L., Erez O., et al. The fetal inflammatory response syndrome. Clin Obstet Gynecol 2007, 50:652-683.
22. Wynn J.L., Neu J., Moldawer L.L., Levy O. Potential of immunomodulatory agents for prevention and treatment of neonatal sepsis. J Perinatol 2009, 29(2):79-88.
23. Harding D., Dhamrait S., Millar A., Humphries S., Marlow N., Whitelaw A., et al. Is interleukin-6-174 genotype associated with the development of septicemia in preterm infants?. Pediatrics 2003, 112:800-803.
24. Chauhan M., McGuire W. Interleukin-6 (-174C) polymorphism and the risk of sepsis in very low birth weight infants: meta-analysis. Arch Dis Child Fetal Neonatal Ed 2008, 93:F427-F429.
25. Hofmann S.R., Ettinger R., Zhou Y.J., Gadina M., Lipsky P., Siegel R., Candotti F., O'Shea J.J. Cytokines and their role in lymphoid development, differentiation and homeostasis. Curr Opin Allergy Clin Immunol 2002, 2:495-506.
26. Takatsu K., Kouro T., Nagai Y. Interleukin 5 in the link between the innate and acquired immune response. Adv Immunol 2009, 101:191-236.
27. Jones S.A. Directing transition from innate to acquired immunity: defining a role for IL-6. J Immunol 2005, 175:3463-3468.
28. Moore K.W., de Waal M.R., Coffman R.L., O'Garra A. Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol 2001, 19:683-765.
29. Ware C.F. Network communications: lymphotoxins, LIGHT, and TNF. Annu Rev Immunol 2005, 23:787-819.
30. Hoyer K.K., Dooms H., Barron L., Abbas A.K. Interleukin-2 in the development and control of inflammatory disease. Immunol Rev 2008, 226:19-28.